Capital Asset Advisory Services LLC Dexcom Inc Transaction History

Capital Asset Advisory Services LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$114.22 - $140.1 $3,312 - $4,062	-29 Reduced 1.73%	1,644 $228,000
Q4 2023 Jan 09, 2024	BUY	$75.49 - $124.16 $126,294 - $207,719	1,673 New	1,673 $207,000
Q2 2023 Aug 02, 2023	BUY	$112.47 - $130.98 $164,768 - $191,885	1,465 New	1,465 $188,000
Q4 2022 Mar 08, 2023	BUY	$84.98 - $122.67 $147,695 - $213,200	1,738 New	1,738 $196,000
Q2 2022 Aug 11, 2022	SELL	$67.99 - $132.89 $47,457 - $92,757	-698 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$94.08 - $130.2 $18,251 - $25,258	-194 Reduced 21.75%	698 $357,000
Q4 2021 Feb 04, 2022	SELL	$129.87 - $162.82 $20,259 - $25,399	-156 Reduced 14.89%	892 $479,000
Q3 2021 Oct 14, 2021	SELL	$106.71 - $143.18 $23,796 - $31,929	-223 Reduced 17.55%	1,048 $573,000
Q2 2021 Aug 06, 2021	BUY	$80.99 - $107.93 $102,938 - $137,179	1,271 New	1,271 $543,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Asset Advisory Services LLC with notifications on news.